Literature DB >> 12422914

Screening for antimalarial toxicity: current concepts.

Michael Easterbrook.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12422914     DOI： 10.1016/s0008-4182(02)80001-1

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN： 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  5 in total

1.  Hydroxychloroquine screening.

Authors:  A G Lee
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

Review 2.  Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.

Authors:  V Peponis; V C Kyttaris; S E Chalkiadakis; S Bonovas; N M Sitaras
Journal:  Lupus       Date:  2010-02-09       Impact factor: 2.911

Review 3.  A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.

Authors:  Nathalie Costedoat-Chalumeau; Bertrand Dunogué; Gaëlle Leroux; Nathalie Morel; Moez Jallouli; Véronique Le Guern; Jean-Charles Piette; Antoine P Brézin; Ronald B Melles; Michael F Marmor
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

4.  Use of antimalarials in dermatology.

Authors:  Falk R Ochsendorf
Journal:  J Dtsch Dermatol Ges       Date:  2010-07-29       Impact factor: 5.584

Review 5.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.